CYTOCHROME P450 7B1 F470I MUTATION AFFECTS ON LIGAND BINDING PROPERTIES

Yaraslau Dzichenka1, Eugene Hudny1, 2

1 Institute of Bioorganic Chemistry, National Academy of Sciences, Belarus

2 Department of Biology, Belarusian State University, Belarus

Human steroid $7\alpha$-hydroxylase (CYP7B1, EC 1.14.13.100) is a microsomal liver enzyme, which takes part in the biosynthesis of intermediate bile acid products. In addition to liver cells. Human cells of the testes, ovary, kidneys and small intestine, prostate gland, large intestine and brain express CYP7B1 [1]. CYP7B1 hydroxylates various oxysterols and neurosteroids, for example DHEA (dehydroepiandrosterone), EPIA (epiandrosterone) [2, 3]. CYP7B1 dysfunction in the human body is associated with the development of a neurodegenerative disease with spastic paraplegia type 5a and osteoarthritis. However, the molecular mechanisms of these diseases are not fully understood due to lacking of information about chemical and physical properties of mutant form of the enzyme.

The aim of this work was to characterize the chemical and physical properties of the mutant form of CYP7B1 with the amino acid substitution Phe470Ile, associated with spastic paraplegia type 5a. For this, we screened the ligands of the active center of the mutant protein form and compared it with the existing data for the wild type. Screening was performed using spectrophotometric titration. To assess the ability of a potential ligand to bind to a protein, we used the constant of dissociation ($K_d$) of enzyme-ligand complex. There was found that five new ligands bind with protein mutant (Fig. 1): $5\beta$-androstane-17-one, $5\beta$- androstane -$3\beta$-ol-16-one, $5\alpha$- androstane-3-one, 5-androstane-$3\beta$, $17\alpha$-diol, 5-androstane-$3\beta$-ol-16–one, in contrast to the wild type.

Figure 1
Fig. 1. The calculated value of the dissociation constant ($K_d$) of the ligand-enzyme complex for CYP7B1 (WT) and CYP7B1_Phe470Ile (F470I).

The data obtained indicate that the enzyme retains the ability to bind steroids and their derivatives, but the substrate profile for binding changes. The results of accelerated molecular dynamics that we have published previously indirectly indicate changes in the structure of the active center of the mutant protein that can explain the change in the ligand profile [4]. However, for an accurate and complete understanding of the changes caused by the Phe470Ile mutation, further experiments are required both in silico and in vitro.


[1] S. Steckelbroeck et al, Characterization of the dehydroepiandrosterone (DHEA) metabolism via oxysterol 7alpha-hydroxylase and 17-ketosteroid reductase activity in the human brain, J. Neurochem. 83 (3), 713-726 (2002).

[2] A.R. Stiles et al, CYP7B1: one cytochrome P450, two human genetic diseases, and multiple physiological functions, J. Biol. Chem.284(42), 28485-28489 (2009).

[3] Y. Akwa et al, Neurosteroid metabolism. 7 alpha-Hydroxylation of dehydroepiandrosterone and pregnenolone by rat brain microsomes, Biochem. J. 288(3), 959-964 (1992)

[4] Dzichenka, Y. V. Cytochrome P450 7B1 F470I mutation affects on protein structure stability / Y. Dzichenka, E. Gudnyy, S. Smolskaya // The 61th Scientific Conference for Young Scientists of Physics and Natural Sciences Open Readings 2018, Vilnius, Lithuania, March 20-23, 2018. / Vilnius University; – Vilnius, 2018. – P. 302.